Smoore International Director Increases Stake by HK$199 million

Apr.14

Smoore International director Xiong Shaoming increases stake by HK$199 million, raising ownership to 39.40%.

According to documents disclosed by The Stock Exchange of Hong Kong on April 11th, Xiong Shaoming, Executive Director and Deputy General Manager of Smoore International, increased his holdings in Smoore International (06969.HK) by purchasing 19.792 million shares at an average price of 10.0333 Hong Kong dollars per share on April 9th, with a total value of approximately 199 million Hong Kong dollars. After the purchase, Xiong Shaoming now holds a total of 2.436 billion shares, increasing hislong position from 39.08% to 39.40%.

Editor's note: A long position is a category in the Hong Kong Stock Exchange's shareholders' equity change table. It refers to major shareholders holding equity in the company, including holding, selling, or issuing financial instruments (including derivative instruments) to maintain ownership. As a result, they have rights and responsibilities such as those listed below, making them "long" holders.

References:

[1] 思摩尔国际(06969.HK)获熊少明增持1,979.2万股普通股股份，价值约1.99亿港元

[2] 表格3A - 董事／最高行政人员通知- 上市法团股份权益

Also Read:

[1] Smoore International Reports Decline in Profits for Q1 2025

[2] Smoore International 2024 Earnings Report: Net Profit Down 20%, HNB Positioned as Second Growth Driver

[3] Smoore 2024 Earnings Report: Revenue Up 5% to $1.63 Billion, Net Profit Down 20% to $180 Million

[4] Smoore Technology's Skincare Brand Secures Class II Medical Device Certificate

[5] 2Firsts Exclusive: Cinda Securities Analyst Weighs in on Smoore’s Market Value-Linked Incentives as Company Eyes Ambitious Growth

[6] Smoore Launches Equity Incentive Plan Targeting HKD 500 Billion Market Value, Shares Surge Over 15% on December 30th Opening

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

NZ Issues National High Alert on Etomidate-Laced Vapes After Hospitalisations

New Zealand’s High Alert drug harm monitoring system has issued a public High Alert warning after multiple hospitalisations linked to illicit vape pods containing the anaesthetic etomidate. Known on the street as space oil, k-pods, or eto, these vapes were first detected in January 2025. Customs has since seized additional samples, and clinics nationwide report rising cases of poisoning and hypoglycaemia.

Nov.04 by 2FIRSTS.ai

WHO Chief Warns of E-Cigarette Threat to Youth as COP11 Opens in Geneva

More than 1,400 delegates from 162 Parties convened in Geneva on November 17 for the Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (WHO FCTC). WHO Director-General Tedros Adhanom Ghebreyesus opened the session with a stark warning: tobacco and nicotine companies are targeting schools as the “new front line” to recruit a generation of addicts through e-cigarettes and nicotine pouches.

Nov.18 by 2FIRSTS.ai

2FIRSTS Data Insight｜China’s Vape Exports to the U.S. Hit a Record $590 Million: A Peak Driven by Enforcement Cycles, Not Real Demand

China’s vape exports to the U.S. surged to a record $590 million in October 2025—nearly double the usual monthly level and pushing the U.S. share above 50% of China’s global shipments.But the spike was not driven by demand. Instead, it reflected a temporary release created by tightened U.S. enforcement, a collapsed logistics pathway, and a bullwhip-style surge in replenishment.The peak signals more volatility ahead, not recovery.

Special Report

Nov.24

South Korea Plans Unified Regulation for Synthetic and Look-Alike Nicotine Products